Photodynamic therapy augments the efficacy of oncolytic vaccinia virus against primary and metastatic tumours in mice.
about
Animal models for photodynamic therapy (PDT)Preclinical evaluation of engineered oncolytic herpes simplex virus for the treatment of neuroblastomaNear Infrared Photoimmunotherapy Targeting EGFR Positive Triple Negative Breast Cancer: Optimizing the Conjugate-Light RegimenPreclinical evaluation of oncolytic vaccinia virus for therapy of canine soft tissue sarcomaEarly assessment of tumor response to photodynamic therapy using combined diffuse optical and diffuse correlation spectroscopy to predict treatment outcome.Characterization and evaluation of a new oncolytic vaccinia virus strain LIVP6.1.1 for canine cancer therapyVirotherapy of canine tumors with oncolytic vaccinia virus GLV-1h109 expressing an anti-VEGF single-chain antibody.CXCL12/CXCR4 blockade by oncolytic virotherapy inhibits ovarian cancer growth by decreasing immunosuppression and targeting cancer-initiating cells.The role of photodynamic therapy in overcoming cancer drug resistance.Targeting CXCL12/CXCR4 signaling with oncolytic virotherapy disrupts tumor vasculature and inhibits breast cancer metastasesImproved micro-distribution of antibody-photon absorber conjugates after initial near infrared photoimmunotherapy (NIR-PIT).Targeting tumor vasculature through oncolytic virotherapy: recent advances.Reprogramming antitumor immunity against chemoresistant ovarian cancer by a CXCR4 antagonist-armed viral oncotherapy.The effect of photoimmunotherapy followed by liposomal daunorubicin in a mixed tumor model: a demonstration of the super-enhanced permeability and retention effect after photoimmunotherapyShifting focus in optical image-guided cancer therapy.Oncolytic viruses as platform for multimodal cancer therapeutics: a promising land.Antiviral activity of extracts from Morinda citrifolia leaves and chlorophyll catabolites, pheophorbide a and pyropheophorbide a, against hepatitis C virus.Modulation of the Tumor Microenvironment by CXCR4 Antagonist-Armed Viral Oncotherapy Enhances the Antitumor Efficacy of Dendritic Cell Vaccines against Neuroblastoma in Syngeneic Mice
P2860
Q26785484-CA485191-75CC-4E9F-B24B-6D86C304EC66Q27303714-786B5D29-E336-45AF-8C59-1F6CA0173DDFQ27320934-7903EE38-A89A-4128-962E-433014F8AD0BQ28729948-F28131A3-9B0F-4A4C-A61B-D848944E3EEAQ30358075-3C18E299-1132-4E76-80E4-85D34BD762EDQ34307934-707DF38C-DED5-4D93-BFB3-B8938DF94590Q34455259-3D62A683-D69C-427C-9EAF-A1A3DE5483C5Q34476278-89A6B0FF-9F12-4095-8A8D-3E6222D39C39Q35904547-F7B77298-54B7-4168-815A-A5FCADC656D4Q36747524-CC098663-3D50-4AE3-92E1-595C8D436726Q36971132-47A1E1A6-FD32-4442-B8E2-102FCDBACD5BQ37031932-AD928DEF-7BE7-4A3E-BAC4-AA540464AA67Q37502464-52141851-F51A-420C-9800-DA40C42FDC16Q37623751-5A17DBD6-FB23-42DF-BD22-2457078F6A8FQ38137710-15F6A437-90B8-4DB9-ABD6-14219A8943C1Q42205615-DC574A06-2EB8-4001-9DAD-36E532D32ECFQ42242645-73E79CDA-ACE9-4BA5-951D-D61871E0EE0CQ58701885-2447EDC5-F54D-47F2-A4E0-FD588BDD8141
P2860
Photodynamic therapy augments the efficacy of oncolytic vaccinia virus against primary and metastatic tumours in mice.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Photodynamic therapy augments ...... nd metastatic tumours in mice.
@ast
Photodynamic therapy augments ...... nd metastatic tumours in mice.
@en
type
label
Photodynamic therapy augments ...... nd metastatic tumours in mice.
@ast
Photodynamic therapy augments ...... nd metastatic tumours in mice.
@en
prefLabel
Photodynamic therapy augments ...... nd metastatic tumours in mice.
@ast
Photodynamic therapy augments ...... nd metastatic tumours in mice.
@en
P2093
P2860
P356
P1476
Photodynamic therapy augments ...... nd metastatic tumours in mice.
@en
P2093
M Bieniasz
M J Ciesielski
M Seshadri
R K Pandey
P2860
P2888
P304
P356
10.1038/BJC.2011.429
P407
P577
2011-10-11T00:00:00Z